A Cure for Nasal Polyps Case Report-Jonathan Wright

by | Jun 1, 2019

Nasal polyps, Helicobacter pylori, Psoriasis, Psorizide®

One Cure for Nasal Polyps: A Case Report

By Jonathan Wright, MD

Originally appeared in Green Medicine Newsletter (January 2019)

An otherwise healthy woman in her 60s (we’ll refer to her as Audrey) started to notice mild breathing obstruction in her sinuses, “kind of like starting to catch a cold.” There was no fever, mucous discharge, or any other symptom indicating infection. The problem gradually worsened; she felt “totally congested” and developed a snore which became worse and worse. She needed two pillows under her head to sleep at night.

She visited an ENT physician who looked as far as possible into her sinuses, then ordered a “CT scan.” At follow-up, she was told she had “a bad case of nasal polyps,” and that the scan showed her sinuses were “almost totally clogged” by the polyps, with only an occasional “clear air pocket” showing on the x-ray. She was advised to have surgery to remove the polyps.

She asked the ENT physician if surgical removal of all the nasal polyps would permanently eliminate the problem. She was advised that at the very least her breathing would be a lot better for a while, but often the polyps return. She asked how often polyps return and was told “ultimately, more than half the time.” She declined surgery and started searching online for causes and alternative treatments. Unfortunately, all the websites she visited kept repeating that the cause of nasal polyps is unknown, citing allergic rhinitis, asthma, aspirin allergy, sinus infections, “something stuck in the nose.”1

The Cause of Nasal Polyps Has Been Found

Fortunately, researchers at universities in Poland,2 Iran,3 Croatia,4 India,5 and again from Iran6 have determined the actual cause of nasal polyps. (Also, fortunately, their reports were printed in English, so I could read them!)

The cause of nasal polyps was first disclosed in 2011 in the titles of the Polish and Iranian research reports, and repeated in the 2012, and two 2016 research reports:

  • Poland (2011) “Detection of Helicobacter pylori and cagA gene in nasal polyps and benign laryngeal diseases.”

  • Iran (2011) “Helicobacter pylori-DNA in nasal polyp tissues in comparison with inferior nasal turbinate tissues: A case control study in Tehran, Iran.”

  • Croatia (2012) “The significance of Helicobacter pylori in patients with nasal polyposis.”

  • India (2016) “Detection of Helicobacter pylori in Nasal Polyps.”

  • Iran (2016) “Helicobacter pylori in nasal polyp formation: A case-control study in Tehran, Iran.”

The consensus is obvious: Nasal polyps are caused by an infection with the bacteria Helicobacter pylori! It’s also obvious why polyps return in the majority of those who have their polyps surgically removed: surgery can’t possibly remove a bacterial infection!

Many Green Medicine Newsletter readers likely are aware that Helicobacter pylori (often termed “H. pylori”) is the cause of stomach ulcers, and that “modern medicine” (in this case, an ironic term) treats Helicobacter pylori with patent medicines, such as a combination of two antibiotics and a patented “acid blocker,” a combination often called “triple therapy.” So why isn’t this—or a version of it—used by “modern medicine” against nasal polyps? Although it can’t be said (or written) for certain, it’s quite possible that much of “modern medicine” isn’t even aware of the nasal polyp research cited above!

A Psoriasis Treatment to Target H. pylori

Is there a better, more targeted treatment against H. pylori than “modern medicine’s” routine “triple therapy”? This better H. pylori remedy was developed in the early 1990s by dermatologist Stephen Smith, MD, but not as treatment for H. pylori, but as a remedy for psoriasis. Dr. Smith published research7 demonstrating its effectiveness in 1997. (That this treatment works by killing H. pylori only became obvious years later.)

The research reported in 1997 used the earliest form of Psorizide® (nickel dibromide) or a placebo. Patients suffering with psoriasis took either Psorizide® first and then the placebo, or the placebo first, then Psorizide®. (The patients were not informed of which one they were taking at any time; for the technically inclined, this is termed “double-blind, crossover” research.) When using Psorizide®, psoriasis was cleared to a significantly greater degree than when the placebo was used.

As Dr. Smith tells us, it “felt like a brick wall” trying to get FDA “approval,” so—because homeopathy was legalized “federally” in the 1930s and exempted from FDA jurisdiction—Dr. Smith switched to homeopathic formulations containing nickel sulfate 1x, potassium bromide 1x, and fumaric acid 1x (Psorizide Forte®)8 or nickel sulfate 1x, potassium bromide 1x, and zinc bromide 4x (Psorizide Ultra®).9

Psorizide® in its various forms had helped many individuals consulting at Tahoma Clinic to either clear or significantly improve their psoriasis.

In 1997, there was no research available that linked either psoriasis or nasal polyps with H. pylori. Research linking psoriasis and H. pylori appears to have started—as did the proof of Helicobacter (also called “H. pylori) causing stomach ulcers—with single cases. One case was reported10 in a “letter to the editor” in 2007, with before and after photographs. It was titled “Complete remission of palmoplantar [palms of the hands, soles of the feet] psoriasis through Helicobacter pylori eradication: a case report.”

In this case report, a 35-year-old man was described (and photographed) with this severe form of psoriasis. He had been given a “breath test” (routinely used in “modern medicine” for diagnosis of H. pylori infection) which was found to be positive for H. pylori infection. He was given the usual (for “modern medicine”) H. pylori (often called “triple therapy”) treatment of amoxicillin and clarithromycin along with a stomach acid blocker, omeprazole. After six weeks of this treatment, the psoriasis started to fade; a year later, the psoriasis was completely gone. (The researchers did not state whether the treatment noted above was used for the entire year.)

Another single case was also reported11 in another “letter to the editor” published the next year. Titled “Clearance of chronic psoriasis after eradication therapy for Helicobacter pylori infection” (and accompanied by photographs), the letter described a 48-year-old woman with “severe and extensive” psoriasis affecting her everywhere except her face and scalp for “at least” the prior fifteen years. She also had been diagnosed with H. pylori infection.

She noticed a major improvement in her psoriasis starting just two weeks after beginning treatment for H. pylori. (The authors of the “letter to the editor” were careful to point out that she took no other treatment for psoriasis during that time.) They concluded: “There is no doubt that our patient’s psoriasis has improved after the eradication of the H. pylori gastric infection.”

Since these case studies were published, there have been many conflicting reports about H. pylori and psoriasis. In 2018 a “meta-analysis” of this topic was published.12 (A “meta-analysis” is not original research; it’s a comprehensive review of all available previously published research reports and reviews.) Although the reviewers could not determine exactly how H. pylori is related to psoriasis, they concluded: “This meta-analysis has shown an increased H. pylori infection in patients with psoriasis.”  

2 + 2 = 4

Nasal polyps might be cleared with Psorizide, and they were! My math skills have always been weak (just ask my math teachers). However, from time to time it seems to me that 2+2 does equal 4, so in this circumstance putting together the 2007 case reports of clearance of psoriasis with “triple therapy” for H. pylori, along with the 2011 through 2016 reports that nasal polyps are infested with H. pylori, it seemed obvious that if Psorizide® might kill the H. pylori associated with psoriasis, it might also kill the H. pylori associated with nasal polyps, and clear them too. And likely (as Dr. Smith’s interview and my own experience observes) there would be many, many fewer adverse effects than with “triple therapy.”

Audrey listened patiently while all of that was explained and decided she’d rather try the Psorizide®; and if that didn’t work, she might consider the “triple therapy,” which—if it happened—we agreed should be reduced to “double therapy” without the acid blocking medication. “Don’t think there’s any acid produced in my nose, or anyone else’s either,” she observed.

During the first week or two of Psorizide® use, she didn’t notice any difference in her breathing. The third week she started having nosebleeds lasting for a few minutes or longer. After that she continued to have heavier and more frequent nosebleeds once or twice weekly. Many appeared to contain not only blood but also bits and pieces of pinkish tissue. Then the surprise: a heavier nosebleed containing blood and bits of tissue and an entire nasal polyp! Not kidding: she took a picture of it with her cell phone and showed me!

As the nosebleeds continued, she “looked at the bright side,” saying, “I’m reducing my heart attack and stroke risk with these nosebleeds, I don’t need to donate blood until after the nosebleeds have stopped for a while!”13 (She also kept track of her blood count and serum iron—not serum ferritin—to make sure she didn’t become actually anemic, which despite the once or twice weekly nosebleeds, she didn’t.)

After almost a month of this, she couldn’t help but notice that she was breathing more easily. After two months, she was breathing significantly better; and the nosebleeds had diminished in frequency and quantity, tapering to once weekly and then stopping altogether after approximately three months. She was breathing freely, no longer snoring at all, and was able to “sleep flat” without pillows if she wanted to do that. As a precaution, she tapered the treatment to nothing over the next few weeks, has had no more problems breathing, and no recurrence at all of nosebleeds in the last two years.

How Does Psorizide® Kill H. pylori?

At present, there’s no verified “mechanism of action” (scientese for “how the **** does this work”) for how Psorizide® kills H. pylori. There’s at least one clue though: H. pylori likes nickel! No, not kidding, H. pylori really does! According to one authority: “It [nickel]…. is an essential element and critical for the pathogenicity of Helicobacter pylori. Nickel is essential for the activity of two of H. pylori’s essential enzymes, urease and hydrogenase. Several studies revealed that these enzymes are important for colonization of the host gastric mucosa.”14 (In English, nickel is essential for H. pylori to invade the cells lining the stomach, and (presumably) nasal polyps.) Another research report15 tells us that H. pylori bacteria store nickel inside themselves to help them invade tissues!

While nickel is very important for H. pylori, bromide appears to be detrimental to this bacteria. As Dr. Smith says in the interview, Israeli researchers had reported that in individuals successfully treated for psoriasis at the “Dead Sea” in Israel, serum bromide levels were significantly higher after treatment than before treatment. It’s just a thought—not proven at all—that H. pylori likes nickel so much that it gobbles the nickel and bromide together, and the bromide kills the H. pylori.

Facts are that Psorizide® has both the nickel that H. pylori likes a lot and the bromide which appears to kill it. Perhaps the other natural components (zinc, fumaric acid, sulfate) in the other homeopathic forms of Psorizide® contribute to killing it too! Only time and further research will tell us.

For now, Psorizide®—Psorizide Forte®, specifically, for Audrey—has cleared one case of nasal polyps, and no signs or symptoms of them have returned in the two years since they departed via nosebleeds rather than being removed surgically.

If you have nasal polyps, you might consider showing this article to your physician. If you’re a physician, this treatment for nasal polyps—which appears to treat the cause—might be worth considering for your patients with nasal polyps! And of course, warn them of potential nosebleeds while the polyps—and the Helicobacter pylori that research has reported nasal polyps to contain—are departing.

The author has no financial connection with the product Psorizide® or the company which manufactures Psorizide®


  1. References

    . For a recent example, see www.webmd.com/allergies/nasal-polyps-symptoms-and -treatments#1↩︎

  2. . Burduk PK, et al. Detection of Helicobacter pylori and cagA gene in nasal polyps and benign laryngeal diseases. Arch Med Res. 2011 Nov;42(8):686-9.↩︎

  3. . Samileh Noorbakhsh, Azardokht Tabatabaei, Mohammad Farhadi, and Ahmad Reza Shamshiri Helicobacter pylori-DNA in nasal polyp tissues in comparison with inferior nasal turbinate tissues: A case control study in Tehran, Iran. Journal of Infectious Diseases and Immunity Vol. 3(4), pp.73-78, April, 2011↩︎

  4. Včeva A, Danić D, Včev A, Birtić D, Mihalj H, Zubčić Z, Kotromanović Z, DanićHadžibegović A. The significance of Helicobacter pylori in patients with nasal polyposis. Med Glas Ljekkomore Zenicko-dobojkantona. 2012 Aug;9(2):281-6.↩︎

  5. Divya Bansal, Sonal Sharma, Sarla Agarwal, Rumpa Saha, Neelima Gupta. Detection of Helicobacter pylori in Nasal Polyps. Head and Neck Pathol (2016) 10:306–313↩︎

  6. Mohammad Farhadi, Mohammad Shokrolahi, Samileh Noorbakhsh, Azardokht Tabatabaei. Role of Helicobacter pylori in nasal polyp formation: A case-control study in Tehran, Iran DOI : 10.14302/issn.2379-8572.joa-15-814↩︎

  7. Smith SA, Young Tr, et al. Improvement of Psoriasis with Nickel Dibromide. Arch Dermatol 1997;133:661-663↩︎

  8. www.drugs.com/pro/psorizide-forte.html↩︎

  9. www.drugs.com/pro/psorizide-ultra.html↩︎

  10. Hubner AM, Tenbaum SP “Complete remission of palmoplantar psoriasis through Helicobacter pylori eradication: a case report”. Clinical and Experimental Dermatology 2007;33:339-340↩︎

  11. Ali M, Whitehead M “Clearance of chronic psoriasis after eradication therapy for Helicobacter pylori infection”. Journal of the European Academy of Dermatology and Venereolgy 2008:22;745-775↩︎

  12. Yong WC,  Upala S, Sanguankeo A Association between Psoriasis and Helicobacter pylori Infection: A Systematic Review and Meta-analysis Indian J Dermatol. 2018 May-Jun; 63(3): 193–200.↩︎

  13. See: The Origin of Atherosclerosis by Kenneth Kensey M.D. and Young Cho Ph.D., and/or The Blood Thinner Cure also by Kenneth Kensey M.D., or see “Dramatically Reduce Your Risk of Heart Attack and Stroke” published in Green Medicine Newsletter, June 2016, available @ www.greenmedicinenewsletter.com↩︎

  14. Palizban A., L. Synthesis and evaluation of the complex-forming ability of hydroxypyranones and hydroxypyridinones with Ni (II) as possible inhibitors for urease enzyme in Helicobacter pylori Res Pharm Sci. 2016 Jul; 11(4): 332–342.↩︎

  15. Benoit SL, Miller EF, Maier RJ. Helicobacter pylori Stores Nickel To Aid Its Host Colonization Infection and Immunity 2013;81(2):580-584↩︎

Author

  • Jonathan V. Wright, MD

    Jonathan V. Wright, MD (ND, hon) is the Medical Director of Tahoma Clinic, where he also practices medicine. A Harvard University (A.B. 1965) and University of Michigan graduate (M.D. 1969), he continues to be a forerunner in research and application of natural treatments for healthy aging and illness. Along with Alan Gaby, MD, he has since 1976 accumulated a file of over 50,000 research papers about diet, vitamins, minerals, botanicals, and other natural substances from which he has developed non-patent medicine (non-“drug”) treatments for health problems. Dr. Wright has taught natural biochemical medical treatments since 1983 to thousands of physicians in the USA, Europe, and Japan.

    View all posts

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • 2026 Association of Natural Health Conference

    Douglasville Conference Center Douglasville, GA, United States

    "From Practitioner to Leader: Clinical Excellence, Business Mastery & Sustainable Practice" Discover how clinical excellence, business mastery, and sustainable systems can help practitioners grow into confident leaders and build practices designed for long-term impact. Why Attend? Three days of learning, connection, and growth designed for every stage of your practice journey. Learn from Leading Voices Gain insights from top experts in natural health, holistic wellness, and functional medicine. Hands-On Learning Participate in in-depth workshops, real-world case studies, and interactive sessions you can apply immediately. Meaningful Networking Connect with like-minded professionals, students, and exhibitors who share your passion for natural health. Practical Tools & Approaches Explore new strategies and tools to elevate both your practice and your own health journey. Who Should Attend? This conference is built for a wide community of natural health professionals, educators, and advocates - wherever you are in your journey. Licensed & Clinical Practitioners Doctors, chiropractors, acupuncturists, naturopaths, and functional or integrative medicine practitioners looking to sharpen clinical skills and grow into stronger practice leaders. Allied Health Professionals Bio-feedback technicians and other allied practitioners seeking hands-on training and the latest tools in natural and holistic care. Educators & Students Natural health educators and students entering the […]

  • Food as Medicine Global 2026

    Virtual Event

    Join health professionals, farmers, food producers, researchers, educators, nonprofit leaders, chefs, policymakers, community organizers, food advocates, public health practitioners, nutritionists, and other changemakers as we convene to share knowledge, build partnerships, and explore new possibilities for improving health, strengthening communities, and creating more equitable and sustainable food systems. This year’s program features inspiring speakers and practical examples of collaboration at the intersection of food, health, social justice, and planetary well-being. Together, we’ll explore innovative approaches to Food as Medicine, community-led initiatives, nutrition, public health, regenerative agriculture, and equitable access to healthy food. Whether you work in health care, agriculture, food production, education, research, policy, or community development, you will discover new ideas, meaningful connections, and practical strategies to advance healthier, more resilient communities. Virtual  |  Join from anywhere in the world Check out the Program: https://tinyurl.com/Food-as-Medicine-for-All

  • The Midlife Women’s Health Summit: Evidence-Based Menopause Care in the Era of Longevity Medicine

    The Ritz-Carlton, Pentagon City 1250 S Hayes St, Arlington, VA, United States
    Hybrid Event

    Menopause Care in the Longevity Era Longevity medicine is everywhere right now. Supplements, protocols, influencer clinics, patients walking in with questions about interventions their doctors have never heard of. What's missing from most of it is the evidence. The Midlife Women's Health Summit is three days on what the research actually says about menopause care when you add a longevity lens. What works, what doesn't, what's being oversold, and what to tell the patient sitting in front of you. Co-chaired by Lisa Larkin, MD, FACP, MSCP, IF, Jen Gunter, MD, FRCS(C), FACOG, DABPM, ABPMR, and Lauren Streicher, MD, FACOG, MSCP; three of the clearest voices in women's health on separating data from marketing.

    $995 – $1299

Related Posts

Exposure, Activity, Contribution: Reading Epstein-Barr Findings in the Individual Patient

Robert Lamberton, BSc, FNTP – Epstein-Barr virus accounts for roughly 2% of cancers worldwide, approaching 360,000 new cases and as many as 210,000 deaths each year, and about 95% of adults carry it. In the overwhelming majority, it causes nothing at all.

When a test for an agent is positive in nearly everyone, a positive test is not a finding. It is a background condition.

Read More

Before Gerson: The Forgotten Medical History of Coffee Enemas

By Scott Wilson – In 1875, Dr. J.P. Thomas wrote about using coffee enemas for opium and belladonna poisoning. He referred to cases going back to 1858 and 1859 and described coffee enemas as one of the ordinary means of treatment. That word “ordinary” stopped me. He wasn’t describing an experiment. He was describing something physicians already knew.

Read More

0 Comments

Submit a Comment